174 related articles for article (PubMed ID: 369375)
21. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B).
Utsumi K; Kuribayashi N; Kumakiri S
Acta Pathol Jpn; 1966 May; 16(2):141-50. PubMed ID: 6012525
[TBL] [Abstract][Full Text] [Related]
22. Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats.
Liu HF; Magdalou J; Nicolas A; Lafaurie C; Siest G
Gen Pharmacol; 1991; 22(2):393-7. PubMed ID: 1905251
[TBL] [Abstract][Full Text] [Related]
23. Bioequivalence of norethindrone and ethinyl estradiol for two different weight tablets with the same hormonal content.
Saperstein S; Edgren RA; Ellis DJ; Lee GJ; Kushinsky S; Olmsted A; Mroszczak E
Contraception; 1986 Jun; 33(6):547-57. PubMed ID: 3769481
[TBL] [Abstract][Full Text] [Related]
24. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro.
Weinstein I; Belitsky R; Seedman S; Friegly MJ; Trasher TN
Biochem Pharmacol; 1975 Sep; 24(17):1583-8. PubMed ID: 1191317
[TBL] [Abstract][Full Text] [Related]
25. The pelvic congestive effects of norethindorne plus mestranol.
Boatwright B; Kaufman RH
Fertil Steril; 1968; 19(2):161-71. PubMed ID: 5640704
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB
Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688
[TBL] [Abstract][Full Text] [Related]
27. Biliary stasis after mestranol-norethindrone ingestion. Report of a case.
Sabel GH; Kirk RF
Obstet Gynecol; 1968 Mar; 31(3):375-7. PubMed ID: 5639192
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
Stanczyk FZ; Mroszczak EJ; Ling T; Runkel R; Henzl M; Miyakawa I; Goebelsmann U
Contraception; 1983 Sep; 28(3):241-51. PubMed ID: 6641224
[TBL] [Abstract][Full Text] [Related]
29. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
[TBL] [Abstract][Full Text] [Related]
30. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
Weikel JH; Nelson LW
J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
[TBL] [Abstract][Full Text] [Related]
31. The characterization of sulphated metabolites of norethindrone in human milk after oral administration of contraceptive steroids.
Sahlberg BL
J Steroid Biochem; 1987 Apr; 26(4):481-5. PubMed ID: 3586665
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptives and plasma lipids.
Dhillon MK; Sarkar AK; Gupta AN; Devi PK
J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
[TBL] [Abstract][Full Text] [Related]
33. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
34. Metabolic profiles of endogenous and ethynyl steroids in plasma and urine from women during administration of oral contraceptives.
Sahlberg BL; Landgren BM; Axelson M
J Steroid Biochem; 1987 May; 26(5):609-17. PubMed ID: 3586677
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives and antithrombin III: variations by dosage and ABO blood group.
Burkman RT; Bell WR; Zacur HA; Kimball AW
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1453-8; discussion 1458-60. PubMed ID: 2048592
[TBL] [Abstract][Full Text] [Related]
36. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
Zacur HA; Burkman RT; Kimball AW; Kwiterovich P; Bell WR
J Clin Endocrinol Metab; 1992 Nov; 75(5):1268-72. PubMed ID: 1430087
[TBL] [Abstract][Full Text] [Related]
37. Influence of two contraceptives on induction of mammary cancer in rats.
McCarthy JD
Am J Surg; 1965 Nov; 110(5):720-3. PubMed ID: 5862377
[TBL] [Abstract][Full Text] [Related]
38. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
Kamal I; Hefnawi F; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
[TBL] [Abstract][Full Text] [Related]
39. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
[TBL] [Abstract][Full Text] [Related]
40. Letter: The effect of contraceptive steroids on carbohydrate metabolism.
Davidson MB
Metabolism; 1974 Jul; 23(7):687-90. PubMed ID: 4834911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
